A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Chung Shan Medical University
University of Kansas Medical Center
Memorial Sloan Kettering Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shanghai Pulmonary Hospital, Shanghai, China
Blanco, Dr Antonio Calles MD
Shanghai Chest Hospital
University Hospital Southampton NHS Foundation Trust
Stanford University
Sun Yat-sen University
Dana-Farber Cancer Institute
Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Jiao Tong University School of Medicine
Samsung Medical Center
Augusta University
Chang Gung Memorial Hospital
Peking University Third Hospital
University of Kansas Medical Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Big Ten Cancer Research Consortium
Guangdong Provincial People's Hospital
Fox Chase Cancer Center
Azienda Ospedaliero-Universitaria di Modena
NHS Greater Glasgow and Clyde
Samsung Medical Center
Shanghai Junshi Bioscience Co., Ltd.
Massachusetts General Hospital
Peking Union Medical College
Royal Marsden NHS Foundation Trust
Massachusetts General Hospital
The Netherlands Cancer Institute
Fudan University
Southwest Hospital, China
Guizhou Medical University
Dana-Farber Cancer Institute
Seoul National University Hospital
Guangzhou Institute of Respiratory Disease
University of Washington
Wake Forest University Health Sciences
AIO-Studien-gGmbH
M.D. Anderson Cancer Center
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
University of Kentucky